• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Daily Swing Trade Archive
    • Income Seeker
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Consumer Discretionary

Vape Pen Growth Is Going to Explode

Here are 4 stocks to buy to invest in this trend.
By DEBRA BORCHARDT
Sep 12, 2018 | 09:00 AM EDT
Stocks quotes in this article: CGC, APHQF, TGODF, TLRY

One of the biggest trends to come out of the legalization of marijuana for adult use has been the explosive growth of vape pens. Most people, when they visualize smoking marijuana, they get an image of someone smoking a joint or pipe. This is the traditional method of consuming marijuana -- and so far marijuana flower continues to be the number one seller and joints are now called pre-rolls.

However, that number one position is losing strength as cannabis consumers are making the switch to vape pens. Mature markets like Colorado and Washington have seen the market share grow to 13%-15% today. The fairly new market of Nevada has experienced vape growth from a robust start of 15.7% market share in July of 2017 to 18.7% in May of 2018, according to BDS Analytics. This is the share of the entire market including flower, edibles and other forms or consumption.

When the sales figures just look at the extraction or concentrate products, vape commands as much as 86% of the market in Colorado, Washington and Oregon. In California, it is 71% of all concentrate sales.

In order to get the cannabis oil for the vape pens, the cannabis plant is fed into an extraction machine, and after a multi-step process, a thick brown substance is produced which is called cannabis oil. This product can also be turned into concentrates like shatter, wax and crumble. This is a very pure form of THC that requires a special pipe to smoke and is very potent.

Standard cannabis oil is what is used for vape pens -- and the potency can vary widely from a very light form of THC to heavy. Some vape pens are only made for CBD, which has no psychotropic effect and is only used for wellness products. So not all vape pens are the same.

Convenience

Consumers are drawn to the vape pens because they look very much like an e-cigarette and an observer would have no idea it's a cannabis vape pen, unless they recognized that the smoke smells just a little differently. A vape pen is convenient and easy to pop in a pocket or handbag. It isn't as delicate as a pre-roll and can be carried just about anywhere. A consumer can smoke on the vape pen discreetly, whereas a consumer can't light up a joint without the smoke and smell signaling to everyone what is happening.

The vape pens are more expensive than the traditional flower buds, but consumers like the consistency of the product. Many vape pens will display an estimated number of uses, which consumers like versus the unknown usage of a pre-roll.

So, with the market data supporting the case for vaping, investors would be wise to focus on companies that can deliver this all-important product. Investors should also know that the Canadian market won't allow vaping products at the onset of legal adult-use cannabis sales. Those products will be allowed later.

How to Invest

Organa Brands is a private company, but it is the leader of vape product sales in Colorado. Its O.penVape products are always at the top of the list for product sales. While investors can't jump into this company now, it's worth remembering if the company ever plans to go public. Another way investors can get involved with O.penVape is through Canopy Growth (CGC) . Canopy recently announced a joint venture with Organa Brands to help create vape products for Canopy for the Canadian market.

"We are incredibly excited about this new partnership -- since the inception of Organa Brands, one of the key tenets of our business has been forming smart partnerships with mutually beneficial results. Working with Canopy and Green House has been a surreal moment as we continue to fully recognize the impact of what this deal means for the industry as a whole," said Organa Brands Co-Founder, Jeremy Heidl.

Canopy also acquired Hiku Brands, which signed a deal earlier this year with popular California vape pen company Dosist. Clearly, Canopy saw the writing on the wall.

Aphria  (APHQF) is another great way to access the vape market. This company makes both THC and CBD vape products. While it is headquartered in Canada, the company is also making a big play for the Florida market. Aphria is behind the Liberty Health Sciences Cannabis Education Centers opening up within the state of Florida. These centers provide Aphria products along with home delivery and products can be bought by FL medcard holders.

Evolabs is the second-biggest producer in Colorado, according to BDS Analytics. This company is joining forces with The Green Organic Dutchman (TGODF) for the Canadian market. The combination of certified organic cannabis and a top vape pen sounds like a marriage made in dispensary heaven.

Of course, many "brands" have a vape version in the portfolio. For example, Tilray (TLRY) has access to the vape market through products in its brands Marley Natural, Dutchy and Grail.

This is the key item that investors need to look for when analyzing a cannabis brand company. Does it have a vape product and is the vape product a leader in sales?

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Borchardt had no positions in the securities mentioned.

TAGS: Investing | U.S. Equity | Cannabis | Consumer Discretionary | Healthcare | Consumer | How-to | Markets | Stocks

More from Consumer Discretionary

Retail Read-Through: What Walmart's Earnings Tell Us About Census Sales Stats

Kevin Curran
Feb 19, 2019 11:52 AM EST

Walmart's strong sales are sparking skeptical responses to government statistics.

Fossil Group Gets Rocked Post-Earnings, but Shows Some Resilience, Too

Jonathan Heller
Feb 15, 2019 11:00 AM EST

A disappointing fourth-quarter report initially drove its shares down Thursday, but they regained most of the lost ground by day's end.

Yeti Holdings: Experienced Traders Can Warm Up to the Cooler Maker's Stock

Bruce Kamich
Feb 12, 2019 12:37 PM EST

It still looks like YETI is poised to move higher.

Hasbro Looks Like It Still Is Trying to Figure Out Which Way to Go

Bruce Kamich
Feb 12, 2019 10:03 AM EST

The toymaker sounds like a bullish fundamental story but its charts are not in gear; wait until the charts and story match.

Bearish Activision Blizzard Could Bounce After Its Hard Trashing... Or Not

Bruce Kamich
Feb 12, 2019 9:01 AM EST

The marketplace showed no mercy during ATVI's recent decline.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:42 PM EST KEVIN CURRAN

    Kraft Heinz Hits Numerous ETFs

    Even for those avoiding Kraft Heinz stock, contr...
  • 11:11 AM EST KEVIN CURRAN

    KHC Crashes Through Technical Floor, Options Action Accelerates

    The RSI on Kraft Heinz is reflecting a shockingl...
  • 11:48 AM EST BOB LANG

    Making a Case for Microsoft and Snap

    Mr Softy has long been a laggard and late to the p...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2019 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login